Last reviewed · How we verify

NCT04364490: Copernicus

Rehabilitative Efficacy of a Visual Feedback Device for Locomotion of Post-stroke Patients

Completed NA Last updated 28 April 2020
What this trial tests

NA trial testing Copernicus noVF in Stroke in 162 participants. Completed in 1 December 2019.

Timeline
1 June 2018
Primary endpoint
31 December 2018
1 December 2019

Quick facts

Lead sponsorS.Anna Rehabilitation Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment162
Start date1 June 2018
Primary completion31 December 2018
Estimated completion1 December 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

S.Anna Rehabilitation Institute

Who can join

Adults 35 to 80, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We tested the feasibility and efficacy of a novel body-weight support (BWS) gait training system with visual feedback, called Copernicus®. This computerized device provides highly comfortable, regular and repeatable locomotion in hemiplegic patients, training the ability to transfer weight loading alternately on both feet through visual real-time monitoring of gait parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other S.Anna Rehabilitation Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04364490.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing